180 related articles for article (PubMed ID: 38911030)
1. The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration.
Ma C; Li H; Lu S; Li X
Drug Des Devel Ther; 2024; 18():2329-2346. PubMed ID: 38911030
[TBL] [Abstract][Full Text] [Related]
2. [Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration].
Moshetova LK; Vorob'eva IV; Alekseev IB; Mikhaleva LG
Vestn Oftalmol; 2015; 131(3):34-44. PubMed ID: 26310005
[TBL] [Abstract][Full Text] [Related]
3. A new prospective on the role of melatonin in diabetes and its complications.
Mok JX; Ooi JH; Ng KY; Koh RY; Chye SM
Horm Mol Biol Clin Investig; 2019 Nov; 40(1):. PubMed ID: 31693492
[TBL] [Abstract][Full Text] [Related]
4. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
[TBL] [Abstract][Full Text] [Related]
5. Beyond AREDS: is there a place for antioxidant therapy in the prevention/treatment of eye disease?
Kowluru RA; Zhong Q
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8665-71. PubMed ID: 22065212
[TBL] [Abstract][Full Text] [Related]
6. Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt/β-catenin pathway as revealed by quantitative proteomics.
Yan M; Wang H; Gu Y; Li X; Tao L; Lu P
Exp Eye Res; 2021 Apr; 205():108521. PubMed ID: 33636209
[TBL] [Abstract][Full Text] [Related]
7. Potential of melatonin to treat or prevent age-related macular degeneration through stimulation of telomerase activity.
Rastmanesh R
Med Hypotheses; 2011 Jan; 76(1):79-85. PubMed ID: 20884126
[TBL] [Abstract][Full Text] [Related]
8. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
[TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates oxidative stress and inflammation of Müller cells in diabetic retinopathy via activating the Sirt1 pathway.
Tu Y; Song E; Wang Z; Ji N; Zhu L; Wang K; Sun H; Zhang Y; Zhu Q; Liu X; Zhu M
Biomed Pharmacother; 2021 May; 137():111274. PubMed ID: 33517190
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial dysfunction in age-related macular degeneration: melatonin as a potential treatment.
Mehrzadi S; Hemati K; Reiter RJ; Hosseinzadeh A
Expert Opin Ther Targets; 2020 Apr; 24(4):359-378. PubMed ID: 32116056
[No Abstract] [Full Text] [Related]
11. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
[TBL] [Abstract][Full Text] [Related]
12. The role and therapeutic potential of melatonin in age-related ocular diseases.
Crooke A; Huete-Toral F; Colligris B; Pintor J
J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
[TBL] [Abstract][Full Text] [Related]
13. Melatonin maintains inner blood-retinal barrier via inhibition of p38/TXNIP/NF-κB pathway in diabetic retinopathy.
Tang L; Zhang C; Yang Q; Xie H; Liu D; Tian H; Lu L; Xu JY; Li W; Xu G; Qiu Q; Liu K; Luo D; Xu GT; Zhang J
J Cell Physiol; 2021 Aug; 236(8):5848-5864. PubMed ID: 33432588
[TBL] [Abstract][Full Text] [Related]
14. Ocular fundus auto-fluorescence observations at different wavelengths in patients with age-related macular degeneration and diabetic retinopathy.
Hammer M; Königsdörffer E; Liebermann C; Framme C; Schuch G; Schweitzer D; Strobel J
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):105-14. PubMed ID: 17653752
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
Bandello F; Corvi F; La Spina C; Benatti L; Querques L; Capuano V; Naysan J; Chen X; Sarraf D; Parodi MB; Souied E; Freund KB; Querques G
Br J Ophthalmol; 2016 Dec; 100(12):1611-1616. PubMed ID: 26951773
[TBL] [Abstract][Full Text] [Related]
16. Benefits of micronutrient supplementation for reducing the risk of wet age-related macular disease and diabetic retinopathy: An update.
Battaglia Parodi M; Brunoro A; Tomasso L; Scuderi G
Eur J Ophthalmol; 2020 Jul; 30(4):780-794. PubMed ID: 32329358
[TBL] [Abstract][Full Text] [Related]
17. [Potential of melatonin for prevention of age-related macular degeneration: experimental study].
Stefanova NA; Zhdankina AA; Fursova AZh; Kolosova NG
Adv Gerontol; 2013; 26(1):122-9. PubMed ID: 24003738
[TBL] [Abstract][Full Text] [Related]
18. A Review: Proteomics in Retinal Artery Occlusion, Retinal Vein Occlusion, Diabetic Retinopathy and Acquired Macular Disorders.
Cehofski LJ; Honoré B; Vorum H
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28452939
[TBL] [Abstract][Full Text] [Related]
19. The VEGF paradox: Does diabetic retinopathy protect from age related macular degeneration?
Saravia M; Zeman L; Ingolotti M; Schlaen A
Med Hypotheses; 2017 Nov; 109():156-161. PubMed ID: 29150277
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence of intravitreal triamcinolone acetonide in the management of age-related macular degeneration.
Becerra EM; Morescalchi F; Gandolfo F; Danzi P; Nascimbeni G; Arcidiacono B; Semeraro F
Curr Drug Targets; 2011 Feb; 12(2):149-72. PubMed ID: 20887246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
